OPEN American journal of obstetrics and gynecology | 20 Feb 2021
EM Lokken, GG Taylor, EM Huebner, J Vanderhoeven, S Hendrickson, B Coler, JS Sheng, CL Walker, SA McCartney, NM Kretzer, R Resnick, A Kachikis, N Barnhart, V Schulte, B Bergam, K K, C Albright, V Larios, L Kelley, V Larios, S Emhoff, J Rah, K Retzlaff, C Thomas, BW Paek, RJ Hsu, A Erickson, A Chang, T Mitchell, JK Hwang, R Gourley, S Erickson, S Delaney, CR Kline, K Archabald, M Blain, SM Lacourse and KM Adams Waldorf
During the early months of the coronavirus disease of 2019 (COVID-19) pandemic, risks to pregnant women of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection were uncertain. Pregnant patients can serve as a model for the success of the clinical and public health response during public health emergencies as they are typically in frequent contact with the medical system. Population-based estimates of SARS-CoV-2 infections in pregnancy are unknown due to incomplete ascertainment of pregnancy status or inclusion of only single centers or hospitalized cases. Whether pregnant women were protected by the public health response or through their interactions with obstetrical providers in the early pandemic is poorly understood.
* Data courtesy of Altmetric.com